Sun Pharma Advanced Research Company Limited (SPARC) β Financial Results | 24 June 2026
Sun Pharma Advanced Research Company Limited announced that its trading window will close on July 1, 2026, ahead of unaudited quarterly results for the June 30 quarter, with the board meeting date to be disclosed later.
About Sun Pharma Advanced Research Company Limited (SPARC)
Healthcare Β· Pharmaceuticals Β· Listed on NSE
π‘ Get AI alerts when SPARC files next
Free β’ Daily 5 PM digest β’ Track filings, board meetings, and corporate actions
Track SPARC β Freeπ‘ Ask AI about this filing
π More SPARC filings
- Announcement β 25 September 2026Sun Pharma Advanced Research Company Ltd (SPARC) has announced that its trading window will close on...
- Announcement β 13 August 2026Sun Pharma Advanced Research Company Limited (SPARC) has formally submitted an application to stock ...
- π‘ Board Meeting β 10 August 2026The board approved unaudited standalone and consolidated financial results for Q1 FY26 ending June 3...
- π‘ deviation variation β 10 August 2026The Monitoring Agency Report confirms no deviation in the utilization of proceeds from SPARC's prefe...
- π‘ Board Meeting β 10 August 2026SPARC held its 21st AGM on August 10, 2026, via video conference, where shareholders approved all re...
π₯ Also filed on 24 June 2026
Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only β not investment advice.
Editorial & Data Transparency Notice
This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.
π‘ Get AI alerts when SPARC files new disclosures
Track SPARC filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track SPARC β FreeFree account Β· 2 AI queries/day